CIK 0001856725
- Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 863114789
- Phone
- +1 408-457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-27 | Imran Talat Chief Executive Officer | Shares withheld for taxes | −7,928 | $0.76 | $6K | 461,808 |
| 2026-07-17 | Imran Talat Chief Executive Officer | Purchase | +35,000 | $0.72 | $25K | 469,736 |
| 2026-06-27 | Imran Talat Chief Executive Officer | Shares withheld for taxes | −7,927 | $0.74 | $6K | 434,736 |
| 2026-06-03 | Imran Talat Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +3,800,000 | 3,800,000 | ||
| 2026-03-27 | Imran Talat Chief Executive Officer | Shares withheld for taxes | −9,099 | $0.81 | $7K | 442,663 |
| 2026-03-22 | Imran Talat Chief Executive Officer | Shares withheld for taxes | −8,916 | $1.13 | $10K | 451,762 |
| 2025-12-27 | Imran Talat Chief Executive Officer | Shares withheld for taxes | −7,906 | $1.40 | $11K | 460,678 |
| 2025-09-27 | Imran Talat Chief Executive Officer | Shares withheld for taxes | −9,077 | $0.48 | $4K | 468,584 |
| 2025-06-27 | Imran Talat Chief Executive Officer | Shares withheld for taxes | −9,076 | $0.55 | $5K | 477,661 |
| 2025-05-23 | Imran Talat Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,053,000 | 1,053,000 | ||
| 2024-12-27 | Imran Talat Chief Executive Officer | Sale | −8,014 | $1.41 | $11K | 486,737 |
| 2024-12-09 | Imran Talat Chief Executive Officer | Purchase | +10,296 | $1.94 | $20K | 494,751 |
| 2024-03-21 | Imran Talat Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,085,000 | 1,085,000 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −479,667 | 95,933 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +479,667 | 479,667 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −153,650 | 109,750 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +153,650 | 153,650 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −271,875 | 453,125 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Grant or award · 271875 | +271,875 | 271,875 | ||
| 2023-12-16 | Imran Talat Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −31,252 | 47,699 |
Page 1 of 2 · 34 trades